デフォルト表紙
市場調査レポート
商品コード
1631466

血管形成術用バルーンの市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント別予測、2025年~2030年

Angioplasty Balloons Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 100 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血管形成術用バルーンの市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント別予測、2025年~2030年
出版日: 2024年12月17日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血管形成術用バルーン市場の成長と動向

Grand View Research, Incの最新レポートによると、血管形成術用バルーンの世界市場規模は2030年に34億米ドルに達する見込みで、2025~2030年にかけてCAGR 3.8%で成長すると予測されています。

この成長は、有利な政府施策と冠動脈と末梢インターベンションの増加に起因しています。血管形成術は低侵襲の手技であるため、患者や外科医は高コストのステント留置よりもこの手技を好みます。さらに、血管形成術用バルーンの進歩や地理的範囲の拡大が、今後数年間の市場成長を促進する可能性が高いです。

例えば、2014年12月にMedtronic plcは、末梢動脈疾患の治療用薬剤コーティングバルーンIN.PACT AdmiralのFDA承認を取得しました。また、同社は日本の厚生労働省から上肢末梢動脈疾患の治療として製品承認を取得しています。TREKとMINI TREK、AngioSculpt、Flextomeといったカッティング・スコアリング・バルーンの承認と商品化、新型バルーンの採用増加が市場をさらに牽引するとみられます。

血管形成術用バルーン市場のハイライト

  • 通常のバルーンが2024年に53.8%の最大市場シェアを占めたのは、コストが低く、冠動脈閉塞を治療できるためです。
  • DEBは再狭窄率の低下と大手企業による研究開発投資の増加により、予測期間中に最も急成長するセグメントと予想されます。
  • 2024年には、冠動脈疾患セグメントが53.4%の最大市場シェアを占めました。冠動脈疾患はすべての心臓疾患の中で最も一般的な疾患であり、その発生率が高いためです。
  • 外来手術センターセグメントは、2024年に38.8%のシェアで市場を独占しました。
  • 北米の血管形成術用バルーン市場は、2024年の世界市場で39.1%のシェアを占め、重要な位置を占めています。北米は血管形成術用バルーン市場において支配的な地域であり、先進的な医療インフラ、高い医療費、高齢者の増加がその要因となっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血管形成術用バルーン市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 血管形成バルーン市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 血管形成術用バルーン市場:製品別、推定・動向分析

  • 世界の血管形成術用バルーン市場:製品ダッシュボード
  • 世界の血管形成術用バルーン市場:製品変動分析
  • 世界の血管形成術用バルーン市場(製品別、収益別)
  • 通常のバルーン
  • 薬剤コーティングバルーン
  • 風船を切る
  • スコアリングバルーン

第5章 血管形成術用バルーン市場:用途別、推定・動向分析

  • 世界の血管形成術用バルーン市場:用途ダッシュボード
  • 世界の血管形成術用バルーン市場:用途変動分析
  • 世界の血管形成術用バルーン市場(用途別、収益別)
  • 末梢血管疾患
  • 冠動脈疾患

第6章 血管形成術用バルーン市場:最終用途別、推定・動向分析

  • 世界の血管形成術用バルーン市場:最終用途ダッシュボード
  • 世界の血管形成術用バルーン市場:最終用途変動分析
  • 世界の血管形成術用バルーン市場(用途別、収益別)
  • 外来手術センター
  • 病院
  • カテーテル検査室

第7章 血管形成術用バルーン市場:国、製品、用途、最終用途による地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模、予測動向分析、2018~2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
  • 企業プロファイル
    • Medtronic
    • Boston Scientific Corporation
    • Johnson & Johnson Services, Inc.
    • Abbott
    • CR Bard, Inc.
    • Spectranetics
    • Terumo Medical Corporation
    • Cardinal Health
    • BIOTRONIK
    • Cook Medical
    • ENDOCOR GmbH
    • B. Braun SE
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global angioplasty balloons market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America angioplasty balloons market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe angioplasty balloons market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 30 France angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 31 France angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific angioplasty balloons market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 52 China angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 53 China angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 58 India angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 59 India angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America angioplasty balloons market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE angioplasty balloons market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait angioplasty balloons market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait angioplasty balloons market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait angioplasty balloons market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Angioplasty balloons market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Angioplasty Balloons Market: Product Outlook Key Takeaways
  • Fig. 15 Global Angioplasty Balloons Market: Product Movement Analysis
  • Fig. 16 Global Normal Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Drug Coated Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cutting Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Scoring Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Angioplasty Balloons Market: Application Outlook Key Takeaways
  • Fig. 21 Global Angioplasty Balloons Market: Application Movement Analysis
  • Fig. 22 Global Peripheral Vascular Diseases Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Coronary Vascular Diseases Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Angioplasty Balloons Market: End Use Outlook Key Takeaways
  • Fig. 25 Global Angioplasty Balloons Market: End Use Movement Analysis
  • Fig. 26 Global Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cath Labs Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Global Angioplasty Balloons Market: Region Movement Analysis
  • Fig. 32 North America Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia pacific Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 48 China Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 49 India Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait Angioplasty Balloons Market, 2018 - 2030 (USD Million)
  • Fig. 61 Strategy framework
目次
Product Code: GVR-1-68038-356-0

Angioplasty Balloons Market Growth & Trends:

The global angioplasty balloons market size is expected to reach USD 3.4 billion in 2030 and is projected to grow at a CAGR of 3.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to favorable government policies and increasing coronary and peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients and surgeons prefer this procedure over high-cost stent placements. Furthermore, advancements in angioplasty balloons and expanding geographical reach are likely to propel the market growth in the coming years.

For instance, in December 2014, Medtronic plc received an FDA approval for their drug-coated balloon IN.PACT Admiral for the treatment of peripheral artery disease. The company also received product approval from Japanese Ministry of Health, Labor and Welfare for the treatment of peripheral artery disease in the upper leg. Approval and commercialization of cutting and scoring balloons, such as TREK and MINI TREK, AngioSculpt, and Flextome balloons along with rising adoption of new balloons are likely to drive the market further.

Angioplasty Balloons Market Report Highlights:

  • The normal balloons segment held the largest market share of 53.8% in 2024 due to low costs and ability of these products to treat coronary artery obstruction
  • DEBs are anticipated to be the fastest-growing segment during the forecast period due to lower restenosis rate and increased R&D investments by major companies
  • In 2024, coronary vascular diseases segment held the largest market share of 53.4% due to the high incidence of coronary artery diseases, which are the most common type of all heart diseases
  • The ambulatory surgery centers segment dominated the market with a share of 38.8% in 2024, due to the huge demand for treatments in these settings.
  • North America angioplasty balloons market held a significant position in the global market in 2024, with a share of 39.1%. North America has been a dominant region in the angioplasty balloons market, driven by advanced healthcare infrastructure, high healthcare spending, and a growing elderly population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. Angioplasty Balloons Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiovascular diseases
      • 3.2.1.2. Technological advancements in balloon design
      • 3.2.1.3. Minimally invasive procedures and cost efficiency.
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of angioplasty procedures
      • 3.2.2.2. Risk of complications and re-stenosis
  • 3.3. Angioplasty Balloons Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Angioplasty Balloons Market: Product Estimates & Trend Analysis

  • 4.1. Global Angioplasty Balloons Market: Product Dashboard
  • 4.2. Global Angioplasty Balloons Market: Product Movement Analysis
  • 4.3. Global Angioplasty Balloons Market by Product, Revenue
  • 4.4. Normal Balloons
    • 4.4.1. Normal balloons market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Drug Coated Balloons
    • 4.5.1. Drug coated balloons market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. Cutting Balloons
    • 4.6.1. Cutting balloons market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Scoring Balloons
    • 4.7.1. Scoring balloons market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Angioplasty Balloons Market: Application Estimates & Trend Analysis

  • 5.1. Global Angioplasty Balloons Market: Application Dashboard
  • 5.2. Global Angioplasty Balloons Market: Application Movement Analysis
  • 5.3. Global Angioplasty Balloons Market by Application, Revenue
  • 5.4. Peripheral Vascular Diseases
    • 5.4.1. Peripheral vascular diseases market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Coronary Vascular Diseases
    • 5.5.1. Coronary vascular diseases market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Angioplasty Balloons Market: End Use Estimates & Trend Analysis

  • 6.1. Global Angioplasty Balloons Market: End Use Dashboard
  • 6.2. Global Angioplasty Balloons Market: End Use Movement Analysis
  • 6.3. Global Angioplasty Balloons Market by End Use, Revenue
  • 6.4. Ambulatory Surgery Centers
    • 6.4.1. Ambulatory surgery centers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Cath Labs
    • 6.6.1. Cath Labs market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Angioplasty Balloons Market: Regional Estimates & Trend Analysis by Country, Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Medtronic
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Boston Scientific Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Johnson & Johnson Services, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Abbott
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. C. R. Bard, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Spectranetics
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Terumo Medical Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Cardinal Health
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. BIOTRONIK
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Cook Medical
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. ENDOCOR GmbH
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. B. Braun SE
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives